Rational Design Of Temperature-Sensitive Blood-Vessel-Embolic Nanogels For Improving Hypoxic Tumor Microenvironment After Transcatheter Arterial Embolization
Ling Li,Yiming Liu,Han Li,Xiaopeng Guo,Xiaojun He,Shinan Geng,Hao Zhao,Xiaole Peng,Dingwen Shi,Bin Xiong,Guofeng Zhou,Yanbing Zhao,Chuansheng Zheng,Xiangliang Yang
DOI: https://doi.org/10.7150/thno.28845
IF: 11.6
2018-01-01
Theranostics
Abstract:Transcatheter arterial embolization (TAE) plays an important role in clinical tumor therapy by accomplishing vessel-casting embolization of tumor arteries at all levels and suppressing tumor collateral circulation and vascular re-canalization. In this study, we describe smart blood-vessel-embolic nanogels for improving the anti-tumor efficacy of TAE therapy on hepatocellular carcinoma (HCC).Methods: In this study, an in vitro model composed of two microfluidic chips was used for simulating the tumor capillary network and analyzing artery-embolization properties. Also, blood-vessel-casting embolization of renal arteries was evaluated in normal rabbits. Using a VX2 tumor-bearing rabbit model, the therapeutic efficacy of TAE on HCC was investigated for tumor growth, necrosis, and proliferation. Neovascularization and collateral circulation were evaluated by immunofluorescent detection of hypoxia-inducible factor-la (HIF-1 alpha), vascular endothelial growth factor (VEGF), and CD31 following the TAE therapy of VX2 tumor-bearing rabbits.Results: Sufficient embolization of all eight levels of micro-channels was achieved in a tumor-vessel-mimetic model with two microfluidic chips using PI BI-2240, and was further confirmed in renal arteries of normal rabbit. Effective inhibition of tumor collateral circulation and vascular re-canalization was observed in VX2 tumor-bearing rabbits due to the reduced expression levels of HIF-1 alpha, VEGF, and CD31.Conclusions: The exceptional anti-tumor effect of PIBI-2240 observed in this study suggested that it is an excellent blood-vessel-embolic material for tumor TAE therapy.